• Oncolytic rMeV-Hu191 Induces Apoptosis in Breast Cancer Mode

  2026-05-25

  Zheng et al. present a comprehensive analysis of the recombinant measles virus strain Hu191 (rMeV-Hu191) as an oncolytic agent for breast cancer, revealing multifaceted antitumor effects via apoptosis induction, proliferation inhibition, and cellular senescence. The study's mechanistic and in vivo results suggest rMeV-Hu191 may offer a promising alternative for resistant breast cancers, with implications for future apoptosis pathway research.

• Mitoxantrone Targets ERα DBD-LBD Interface to Overcome Resis

  2026-05-25

  The reference study identifies a novel allosteric inhibition mechanism for estrogen receptor alpha (ERα) via mitoxantrone binding at the DBD-LBD interface, leading to rapid proteasomal degradation and disruption of receptor function. This mechanism is effective against both wild-type and therapy-resistant ERα mutants, providing a new strategy to circumvent endocrine resistance in breast cancer models.

• Concanamycin A: Precision V-ATPase Inhibition in Cancer Biol

  2026-05-24

  Discover how Concanamycin A, a potent V-type H+-ATPase inhibitor, enables targeted disruption of tumor cell survival and invasiveness. This article uniquely explores its mechanistic selectivity, advanced research uses, and new insights from sphingolipid regulation.

• Irinotecan (CPT-11): Workflow Enhancements in Colorectal Can

  2026-05-23

  Harness Irinotecan’s potent topoisomerase I inhibition and proven efficacy for robust DNA damage, apoptosis, and tumor suppression assays. Discover protocol refinements, troubleshooting strategies, and advanced applications that elevate colorectal cancer research with APExBIO’s trusted reagent.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Protocol and QC Guida

  2026-05-22

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) is designed for reliable detection of HMGB1 protein in human, mouse, and rat research samples across Western blot, immunohistochemistry, and flow cytometry. This reagent supports chromatin protein studies but is not validated for diagnostic or therapeutic use.

• Berberine Hydrochloride Expands Tuft Cells to Counter Bone L

  2026-05-22

  A recent study demonstrates that berberine hydrochloride mitigates estrogen deficiency-induced bone loss by promoting intestinal tuft cell expansion through butyrate-GPR41 signaling. This discovery establishes a mechanistic link between the gut-bone axis and osteoimmunity, highlighting new opportunities for postmenopausal osteoporosis research.

• hly Gene Deletion Impairs Biofilm and Antibiotic Resistance

  2026-05-21

  This study investigates the functional role of the hly gene in Listeria monocytogenes, focusing on its impact on biofilm formation, virulence regulation, and antibiotic sensitivity. The findings reveal that hly deletion significantly compromises biofilm architecture and increases susceptibility to antibiotics, with implications for food safety and pathogen control.

• Cy5 Hydrazide: Advancing Precision in Translational Nanobiol

  2026-05-21

  This article explores the mechanistic utility and translational potential of Cy5 hydrazide (non-sulfonated) as a carbonyl-reactive fluorescent dye, elevating biomolecule tracking and protein carbonylation labeling in oxidative stress and food-grade nanoparticle systems. Integrating recent advances in facilitated self-assembly nanotechnology, we deliver strategic guidance for researchers at the interface of analytical biochemistry and next-generation nutraceutical delivery. APExBIO’s Cy5 hydrazide is positioned as a robust alternative to Alexa Fluor 647, with unique workflow insights and protocol parameters for optimal implementation.

• Abiraterone Acetate: CYP17 Inhibitor Workflows in Prostate C

  2026-05-20

  Unlock the full translational impact of Abiraterone acetate as a potent CYP17 inhibitor in cutting-edge prostate cancer research. This guide details optimized workflows, troubleshooting strategies, and highlights from recent advances in 3D patient-derived models, setting the standard for rigorous experimental design.

• HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit: Atomic Insi

  2026-05-20

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit enables robust, high-yield fluorescent RNA probe synthesis through in vitro transcription using Cy5-UTP. This kit provides customizable probe labeling for sensitive detection in in situ and Northern blot hybridization, establishing itself as a standard in research workflows.

• (+)-Bicuculline: Technical Use and Protocol Parameters

  2026-05-19

  (+)-Bicuculline is a classical GABAA receptor antagonist widely utilized in neuroscience research to dissect inhibitory neurotransmission and modulate synaptic NMDA receptor signaling. It is not intended for clinical, diagnostic, or therapeutic use, and rigorous attention to solubility and storage is essential for experimental reproducibility.

• Thiamet G (SKU B2048): Reliable O-GlcNAcase Inhibition in Ce

  2026-05-19

  This article offers scenario-driven guidance for optimizing cell viability, proliferation, and differentiation assays using Thiamet G (SKU B2048), a potent O-GlcNAcase inhibitor from APExBIO. Drawing on recent literature and validated protocols, we address real-world challenges in O-GlcNAcylation modulation, tau phosphorylation inhibition, and workflow reproducibility, with actionable recommendations for biomedical researchers.

• RP3-340N1.2 Knockdown Destabilizes IL-6 to Suppress NSCLC Pr

  2026-05-18

  This study identifies the long non-coding RNA RP3-340N1.2 as an oncogenic factor in non-small cell lung cancer (NSCLC) via stabilization of IL-6 mRNA. Functional knockdown of RP3-340N1.2 enhances IL-6 mRNA degradation through interaction with the RNA-binding protein ZC3H12A, leading to suppressed tumor cell proliferation, migration, and tumor-associated macrophage polarization.

• DAPT (GSI-IX): Protocol Optimization in Notch Pathway Resear

  2026-05-18

  DAPT (GSI-IX) empowers researchers to dissect Notch and amyloid precursor protein signaling with precision, supporting translational studies from neurodegeneration to angiogenesis. This guide outlines actionable workflows, troubleshooting strategies, and advanced use-cases, with insights from cutting-edge reference studies and APExBIO’s validated product specifications.

• Phenacetin: Mechanistic Rigor and Strategic Leverage in Tran

  2026-05-17

  This article explores the renewed role of Phenacetin (N-(4-ethoxyphenyl)acetamide) as a gold-standard reference in modern pharmacokinetic research. We integrate mechanistic insights, recent experimental models, and strategic guidance, highlighting how APExBIO's high-purity Phenacetin supports translational workflows that connect molecular understanding to clinical relevance. By bridging evidence from next-generation organoid platforms and validated analytical protocols, we provide actionable recommendations for researchers targeting precision and reproducibility in drug absorption and metabolism studies.

15410 records 2/1028 page Previous Next 12345 下5页 Last page